Parker’s Journey and the Start of Cure JM

This amazing video details how the Cure JM Foundation started. Twenty years later, Cure JM is the global leader in juvenile myositis (JM) research.

Today, Cure JM celebrates its 20-year commitment as a patient advocacy and juvenile myositis research leader, paving the way to better treatments for JM while improving the lives of families affected by the disease.

Myositis Specific Antibodies (MSAs): What Families Need to Know

Myositis-specific antibodies (MSAs) are associated with certain symptoms in JM patients. In some cases, knowing the MSA of a patient may help clinicians look out for certain symptoms and guide treatment decisions. Dr. Jessica Neely explains these associations, why they are important, and the limitations in our understanding of the role of MSAs in JM.

Researcher discusses chart on wall.

The Importance of Research

Research is vital to finding better treatments and a cure for juvenile myositis. Cure JM funds research studies through our Cure JM Centers of Excellence and the Cure JM Clinical Care Network.

Join Cure JM

Membership is free and we’ll connect you with a network of support, encouragement, and resources.

Cure JM supports families, patients, and the juvenile myositis research community.